Highlights
- 1Scientific reports · 2022
- 2Frontiers in cell and developmental biology · 2024
- 3Nature cardiovascular research · 2025
Publications
22 publications
Funding
13 grantsView NIH portfolio on RePORTER ↗
Active
6 grants- PIR01HL179084-02Identifying Novel Roles and the Therapeutic Potential of the Thrombin Receptor Protease Activated Receptor-1 (PAR1) in Lung Lymphatic Function and Acute Respiratory Distress SyndromeNational Heart, Lung, and Blood Institute · 2025–2029
- Sub-PIR01HL177971-02Lymphatic Dysfunction and Development of Post-Transplant Obliterative BronchiolitisNational Heart, Lung, and Blood Institute · 2025–2028 · via Children's Hospital of Philadelphia
- Co-IT32HL134629-06A1Multidisciplinary Approach Training in Respiratory ResearchNational Heart, Lung, and Blood Institute · 2023–2028
- PIR01HL162990-04Lymphatic Dysfunction in the Pathogenesis of COPDNational Heart, Lung, and Blood Institute · 2023–2028
- Co-IAY2AX000080-01LYMPHATIC IMAGING, GENOMIC AND PHENOTYPING TECHNOLOGIES (LIGHT) / LYMPHATIC DISEASE ADVANCEMENTS WITH NANOTECHNOLOGY, TRANSLATIONAL EPIGENETICS, AND RESEARCH IN GENETICS (LANTERN)Advanced Research Projects Agency for Health · 2025–2027
- KPP01HL114501-06A1Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette SmokersNational Heart, Lung, and Blood Institute · 2021–2027
Completed grants (7)
- PIALA 228174-02Lymphatic Endothelial Cell Crosstalk in Tertiary lymphoid Organ Formation and Lung InjuryAmerican Lung Association, Incorporated · 2023–2025
- KPK08HL165078-01The role of endothelial derived Leucine-Rich Alpha-2-Glycoprotein 1 (LRG1) in the pathogenesis of COPDNational Heart, Lung, and Blood Institute · 2022–2024Career
- KPCA-944164The role of endothelial derived leucine-rich 2-alpha glycoprotein-1 (LRG1) in the pathogenesis of COPDAmerican Lung Association, Incorporated · 2022–2024
- PIK01HL145365-05The Pulmonary Lymphatics in Inflammation and DiseaseNational Heart, Lung, and Blood Institute · 2019–2024Career
- PIRWJ 76511Investigating the Role of the Pulmonary Lymphatics in Inflammatory Chronic Lung DiseaseRobert Wood Johnson Foundation · 2019–2023
- PIATS 222747-01Lymphatic Dysfunction in the Pathogenesis of EmphysemaAmerican Thoracic Society, Inc. · 2022–2023
- PIF31HL090032-05The connection between Notch signaling and VEGFR1 in angiogenesisNHLBI · 2007–2012 · via NIH RePORTER
News mentions
2 mentionsView all WCM news ↗
- How Vessels in the Lungs Switch Gears to Promote HealingJuly 17, 2025
A protein called PAR1 helps lymphatic vessels structurally transform to boost fluid drainage and support healing when the lungs are injured according to researchers from Weill Cornell Medicine.
- Three Weill Cornell Medicine Faculty Win ASCI Young Physician-Scientist AwardsMarch 3, 2022
Three Weill Cornell Medicine faculty members have received Young Physician-Scientist Awards from the American Society for Clinical Investigation. The 2022 award recipients are Drs. Bishoy M. Faltas, Gunisha Kaur and Hasina Outtz Reed.
Mentoring
2 menteesAll publications with mentees →